Testing a closed-loop insulin system for kids with type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial studies how the Medtronic 780G “closed-loop” insulin system works for young people with type 1 diabetes. It may help by improving how automatically insulin is delivered, depending on your body’s needs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have type 1 diabetes
- You must have had type 1 diabetes for at least 6 months
- You need to attend regular clinic visits for this study
- You must be starting or have started using the Medtronic 780G system
- You must be at least 1 year old
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a semi-automated insulin pump system in very young children (ages 2–6) with type 1 diabetes. It aims to see if the device improves quality of life and blood sugar control.
This trial is testing a closed-loop system that automatically adjusts insulin delivery to keep blood sugar in a healthy range, in a simulated hospital setting. If you have type 1 or type 2 diabetes and use insulin, this could help you manage your glucose more effectively.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study invites people who already took part in the Steno780G study to join a follow-up to see how they are doing over time. Participation may help researchers learn more about long-term effects.
This study tests a new insulin pump system (MiniMed 780G) in children aged 7-17 who were recently diagnosed with type 1 diabetes. It aims to see if this pump helps control blood sugar better and improves quality of life compared to standard insulin shots or older pumps.
This study tests a new experimental automated insulin delivery system for people with type 1 or type 2 diabetes who already use a specific insulin pump (MiniMed 780G with Simplera Sync sensor). The goal is to see if the new system is safe and works well to help manage blood sugar.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.